PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ML vs. SRPT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ML and SRPT is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

ML vs. SRPT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MoneyLion Inc. (ML) and Sarepta Therapeutics, Inc. (SRPT). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%AugustSeptemberOctoberNovemberDecember2025
21.83%
-16.76%
ML
SRPT

Key characteristics

Sharpe Ratio

ML:

0.46

SRPT:

0.68

Sortino Ratio

ML:

1.32

SRPT:

1.68

Omega Ratio

ML:

1.16

SRPT:

1.20

Calmar Ratio

ML:

0.46

SRPT:

0.74

Martin Ratio

ML:

1.24

SRPT:

2.05

Ulcer Index

ML:

33.40%

SRPT:

16.94%

Daily Std Dev

ML:

90.65%

SRPT:

50.89%

Max Drawdown

ML:

-97.57%

SRPT:

-98.17%

Current Drawdown

ML:

-76.61%

SRPT:

-29.34%

Fundamentals

Market Cap

ML:

$965.46M

SRPT:

$11.61B

EPS

ML:

$0.29

SRPT:

$1.54

PE Ratio

ML:

296.59

SRPT:

78.95

Total Revenue (TTM)

ML:

$387.32M

SRPT:

$1.24B

Gross Profit (TTM)

ML:

$197.11M

SRPT:

$1.05B

EBITDA (TTM)

ML:

$42.86M

SRPT:

$119.07M

Returns By Period

In the year-to-date period, ML achieves a 0.91% return, which is significantly lower than SRPT's 3.87% return.


ML

YTD

0.91%

1M

-2.56%

6M

21.81%

1Y

36.89%

5Y*

N/A

10Y*

N/A

SRPT

YTD

3.87%

1M

-0.19%

6M

-16.77%

1Y

33.95%

5Y*

-0.54%

10Y*

24.57%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ML vs. SRPT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for MoneyLion Inc. (ML) and Sarepta Therapeutics, Inc. (SRPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ML, currently valued at 0.46, compared to the broader market-4.00-2.000.002.000.460.68
The chart of Sortino ratio for ML, currently valued at 1.32, compared to the broader market-4.00-2.000.002.004.001.321.68
The chart of Omega ratio for ML, currently valued at 1.16, compared to the broader market0.501.001.502.001.161.20
The chart of Calmar ratio for ML, currently valued at 0.46, compared to the broader market0.002.004.006.000.460.74
The chart of Martin ratio for ML, currently valued at 1.24, compared to the broader market0.005.0010.0015.0020.0025.001.242.05
ML
SRPT

The current ML Sharpe Ratio is 0.46, which is lower than the SRPT Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of ML and SRPT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.002.004.006.008.00AugustSeptemberOctoberNovemberDecember2025
0.46
0.68
ML
SRPT

Dividends

ML vs. SRPT - Dividend Comparison

Neither ML nor SRPT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ML vs. SRPT - Drawdown Comparison

The maximum ML drawdown since its inception was -97.57%, roughly equal to the maximum SRPT drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for ML and SRPT. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%AugustSeptemberOctoberNovemberDecember2025
-76.61%
-29.34%
ML
SRPT

Volatility

ML vs. SRPT - Volatility Comparison

MoneyLion Inc. (ML) has a higher volatility of 19.21% compared to Sarepta Therapeutics, Inc. (SRPT) at 7.22%. This indicates that ML's price experiences larger fluctuations and is considered to be riskier than SRPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%AugustSeptemberOctoberNovemberDecember2025
19.21%
7.22%
ML
SRPT

Financials

ML vs. SRPT - Financials Comparison

This section allows you to compare key financial metrics between MoneyLion Inc. and Sarepta Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab